Your browser doesn't support javascript.
loading
Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation.
Gharagozloo, Marjan; Smith, Matthew D; Jin, Jing; Garton, Thomas; Taylor, Michelle; Chao, Alyssa; Meyers, Keya; Kornberg, Michael D; Zack, Donald J; Ohayon, Joan; Calabresi, Brent A; Reich, Daniel S; Eberhart, Charles G; Pardo, Carlos A; Kemper, Claudia; Whartenby, Katharine A; Calabresi, Peter A.
Afiliación
  • Gharagozloo M; Division of Neuroimmunology and Neurological Infections, Johns Hopkins Hospital, Pathology Building 509, 600 N. Wolfe St., Baltimore, Md, 21287, USA.
  • Smith MD; Division of Neuroimmunology and Neurological Infections, Johns Hopkins Hospital, Pathology Building 509, 600 N. Wolfe St., Baltimore, Md, 21287, USA.
  • Jin J; Division of Neuroimmunology and Neurological Infections, Johns Hopkins Hospital, Pathology Building 509, 600 N. Wolfe St., Baltimore, Md, 21287, USA.
  • Garton T; Division of Neuroimmunology and Neurological Infections, Johns Hopkins Hospital, Pathology Building 509, 600 N. Wolfe St., Baltimore, Md, 21287, USA.
  • Taylor M; Division of Neuroimmunology and Neurological Infections, Johns Hopkins Hospital, Pathology Building 509, 600 N. Wolfe St., Baltimore, Md, 21287, USA.
  • Chao A; Division of Neuroimmunology and Neurological Infections, Johns Hopkins Hospital, Pathology Building 509, 600 N. Wolfe St., Baltimore, Md, 21287, USA.
  • Meyers K; Division of Neuroimmunology and Neurological Infections, Johns Hopkins Hospital, Pathology Building 509, 600 N. Wolfe St., Baltimore, Md, 21287, USA.
  • Kornberg MD; Division of Neuroimmunology and Neurological Infections, Johns Hopkins Hospital, Pathology Building 509, 600 N. Wolfe St., Baltimore, Md, 21287, USA.
  • Zack DJ; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, MD, 21205, USA.
  • Ohayon J; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Calabresi BA; The Guerrieri Center for Genetic Engineering and Molecular Ophthalmology, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
  • Reich DS; Neuroimmunology Clinic and Translational Neuroradiology Section National Institute of Neurological Disorders and Stroke, Bethesda, MD, 20892, USA.
  • Eberhart CG; Neuroimmunology Clinic and Translational Neuroradiology Section National Institute of Neurological Disorders and Stroke, Bethesda, MD, 20892, USA.
  • Pardo CA; Division of Neuroimmunology and Neurological Infections, Johns Hopkins Hospital, Pathology Building 509, 600 N. Wolfe St., Baltimore, Md, 21287, USA.
  • Kemper C; Neuroimmunology Clinic and Translational Neuroradiology Section National Institute of Neurological Disorders and Stroke, Bethesda, MD, 20892, USA.
  • Whartenby KA; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Calabresi PA; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
Acta Neuropathol ; 142(5): 899-915, 2021 11.
Article en En | MEDLINE | ID: mdl-34487221
ABSTRACT
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) characterized by varying degrees of secondary neurodegeneration. Retinal ganglion cells (RGC) are lost in MS in association with optic neuritis but the mechanisms of neuronal injury remain unclear. Complement component C3 has been implicated in retinal and cerebral synaptic pathology that may precede neurodegeneration. Herein, we examined post-mortem MS retinas, and then used a mouse model, experimental autoimmune encephalomyelitis (EAE), to examine the role of C3 in the pathogenesis of RGC loss associated with optic neuritis. First, we show extensive C3 expression in astrocytes (C3+/GFAP+ cells) and significant RGC loss (RBPMS+ cells) in post-mortem retinas from people with MS compared to retinas from non-MS individuals. A patient with progressive MS with a remote history of optic neuritis showed marked reactive astrogliosis with C3 expression in the inner retina extending into deeper layers in the affected eye more than the unaffected eye. To study whether C3 mediates retinal degeneration, we utilized global C3-/- EAE mice and found that they had less RGC loss and partially preserved neurites in the retina compared with C3+/+ EAE mice. C3-/- EAE mice had fewer axonal swellings in the optic nerve, reflecting reduced axonal injury, but had no changes in demyelination or T cell infiltration into the CNS. Using a C3-tdTomato reporter mouse line, we show definitive evidence of C3 expression in astrocytes in the retina and optic nerves of EAE mice. Conditional deletion of C3 in astrocytes showed RGC protection replicating the effects seen in the global knockouts. These data implicate astrocyte C3 expression as a critical mediator of retinal neuronal pathology in EAE and MS, and are consistent with recent studies showing C3 gene variants are associated with faster rates of retinal neurodegeneration in human disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Ganglionares de la Retina / Complemento C3 / Enfermedades Neuroinflamatorias / Esclerosis Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Acta Neuropathol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Ganglionares de la Retina / Complemento C3 / Enfermedades Neuroinflamatorias / Esclerosis Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Acta Neuropathol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos